Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Bain

Plastic Surgery Newport Beach, CA Medical Doctor

NPI 1316029341 CMS profile 150816

1 Hoag Dr, Newport Beach, CA 92663

Open in the dashboard

General payments

$341,447

529 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Bain of Newport Beach, CA is reported in the CMS Open Payments database as having received $341,447 across 529 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $72,034 71
2024 General $56,607 57
2023 General $39,562 74
2022 General $57,776 90
2021 General $50,045 86
2020 General $17,898 35
2019 General $47,525 116

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Bain
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Michael Bain were reported at $72,034. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Michael Bain Plastic Surgery median Middle half National median
2019 $47,525 $371 $122–$1,483 $163
2020 $17,898 $158 $52–$438 $114
2021 $50,045 $249 $87–$752 $132
2022 $57,776 $274 $102–$793 $149
2023 $39,562 $299 $113–$891 $160
2024 $56,607 $361 $124–$1,062 $164
2025 $72,034 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Organogenesis Inc. $338,344 485 payments
  2. Avita Medical Americas, LLC $1,636 4 payments
  3. Smith+Nephew, Inc. $749 16 payments
  4. Merck Sharp & Dohme Corporation $187 11 payments
  5. MIMEDX Group, Inc. $176 1 payment
  6. Musculoskeletal Transplant Foundation Inc. $97 1 payment
  7. ConvaTec Inc. $61 2 payments
  8. Mentor Worldwide LLC $45 2 payments
  9. Tactile Systems Technology Inc $32 2 payments
  10. Medline Industries, Inc. $29 1 payment
  11. Other $92 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $181,512 108 payments
  2. Consulting Fee $91,969 21 payments
  3. Travel and Lodging $39,439 200 payments
  4. Honoraria $15,800 12 payments
  5. Food and Beverage $12,727 188 payments
Products named General payments · program years 2019–2025
  1. PURAPLY WOUND MATRIX $110,274 85 payments
  2. Puraply $78,442 150 payments
  3. Affinity $69,459 40 payments
  4. Puraply Antimicrobial $66,782 85 payments
  5. NuShield $61,250 20 payments
  6. APLIGRAF Wound Care $56,453 24 payments
  7. NOVACHOR $52,144 17 payments
  8. Apligraf Podiatry $46,641 93 payments
  9. Puraply/Affinity/NuTech $46,641 93 payments
  10. Dermagraft $46,641 93 payments
  11. Other $29,297 90 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 49 billing codes

Paid by Medicare

$659,277

Medicare's payments for the services billed

Medicare patients

539

Average age 79

Services billed

6,259

279 women, 260 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 62%
Ischemic heart disease 53%
Atrial fibrillation 39%
Chronic kidney disease 35%
Diabetes 34%
Heart failure 29%
Cancer 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

529 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record